Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 268 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Metformin and incretin-based therapies up-regulate central and peripheral Adenosine monophosphate-activated protein affecting appetite and metabolism

Nakano Masako, Inui Akio

Year : 2012| Volume: 16| Issue : 9 | Page no: 529-531

   This article has been cited by
1 The effects of weight loss and metformin on cognition among breast cancer survivors: Evidence from the Reach for Health study
Sheri J. Hartman,Sandahl H. Nelson,Catherine R. Marinac,Loki Natarajan,Barbara A. Parker,Ruth E. Patterson
Psycho-Oncology. 2019; 28(8): 1640
[Pubmed]  [Google Scholar] [DOI]
2 Metformin intervention in obese non-diabetic patients with breast cancer: phase II randomized, double-blind, placebo-controlled trial
Kwang-Pil Ko,Seung Hyun Ma,Jae-Jeong Yang,Yunji Hwang,Choonghyun Ahn,Young-Min Cho,Dong-Young Noh,Byung-Joo Park,Wonshik Han,Sue K. Park
Breast Cancer Research and Treatment. 2015; 153(2): 361
[Pubmed]  [Google Scholar] [DOI]


Read this article